In a recent speech, President Biden overstated the average monthly cost that patients were paying prior to the Inflation Reduction Act: The out-of-pocket cost for insulin was $58 for a 30-day supply, says a HHS report.

Novo Nordisk's list price for a monthly package of Ozempic is $935.77 before insurance and other rebates, yet it can be manufactured for between $0.89 to $4.73 a month, according to researchers at Yale University.

The White House Office of Management and Budget has concluded its review of the Department of Labor's new Retirement Security Rule, indicating that the controversial new rule will become final sometime this Spring.

The DOL's latest iteration, proposed in 2023 and soon to become final, will ensure that advisors prioritize their clients' best interests when recommending investments, prompting employers to make necessary adjustments.

Increasingly, health system consolidations, which must balance short-term and long-term financial goals, are focused on value-based care, which promotes better care for patients and improved health outcomes at reduced prices.

The Biden administration has announced that it has finalized a new regulation that curbs the use of short-term health insurance plans that do not comply with the Affordable Care Act, limiting the plans to 90 days.

The feds face a year-end deadline to solidify or scuttle payment changes for telehealth services that allow people to "visit" a doctor in their homes, however, it's expected that Congress will "kick the can" past the November election.

More patients are losing their doctors — and trust in the primary care system, according to American Medical Association's president, Jesse Ehrenfeld.